RCC2, highly expressed in tumor tissue, showed positive as well as negative correlations with the abundance of most immune cells; it upregulated the tryptophan metabolism, cholesterol metabolism, and signaling pathways regulating pluripotency of stem cells, implying that RCC2 promotes cancer cell growth and differentiation. This evidence concerns the gene RCC2 and neoplasm.